跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NIRABEN CAPSULE 200 MG - HSA Drug Approval Details
Approvals
/
HSA
/
NIRABEN CAPSULE 200 MG
Approved
THERAPEUTIC
NIRABEN CAPSULE 200 MG
APROGEN PHARMACEUTICALS, INC. (KOREA, REPUBLIC OF)
🇸🇬 Health Sciences Authority
Approval Date
Jun 3, 1999
Approval ID
8c83812e1862ddcb
Company
APROGEN PHARMACEUTICALS, INC. (KOREA, REPUBLIC OF)
Type
Therapeutic
Approval Details
Approval Id
8c83812e1862ddcb
Drug Name
NIRABEN CAPSULE 200 MG
Product Name
NIRABEN CAPSULE 200 MG
Approval Number
SIN10966P
Approval Date
1999-06-03
Registrant
ZYFAS PHARMA PTE LTD
Licence Holder
ZYFAS PHARMA PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
CAPSULE
Route Of Administration
ORAL
Atc Code
A07AX03
Atc Item Name
nifuroxazide
Pharma Manufacturer Name
ZYFAS PHARMA PTE. LTD.
Company Detail Path
/organization/zyfas-pharma-pte-ltd
Active Ingredients
NIFUROXAZIDE
200 mg
NIFUROXAZIDE
200 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 3, 1999
Approval ID
8c83812e1862ddcb
Type
Therapeutic
Back to HSA Approvals